PT - JOURNAL ARTICLE AU - Iuliana Badiu AU - Massimo Geuna AU - Enrico Heffler AU - Giovanni Rolla TI - Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80 AID - 10.1136/bcr.02.2012.5797 DP - 2012 May 08 TA - BMJ Case Reports PG - bcr0220125797 VI - 2012 4099 - http://casereports.bmj.com/content/2012/bcr.02.2012.5797.short 4100 - http://casereports.bmj.com/content/2012/bcr.02.2012.5797.full AB - A 17-year-old girl reported generalised urticaria, eyelid angioedema, rhino-conjunctivitis, dyspnoea and wheezing 1 h after third intramuscular administration of quadrivalent human papilloma virus vaccine (Gardasil). She was treated with antihistamine, and corticosteroids with prompt relief of rhinitis and dyspnoea, while urticaria and angioedema lasted 24 h. Intradermal test with Gardasil, which contains polysorbate 80 (PS80), resulted positive, while skin tests with the bivalent vaccine were negative. Prick test performed with PS80 resulted positive in the patient and negative in ten healthy controls. The CD203 basophil activation test result was negative for PS80 at all the tested dilutions and specific IgE was not found. As flu vaccine was recommended, the authors skin tested two flu vaccine, one containing PS80 (Fluarix, GSK), which resulted positive and another flu vaccine with no adjuvant or preservative (Vaxigrip, Sanofi Pasteur MSD), which gave negative results. The patient then received Vaxigrip without adverse reactions.